Isomeric separation of cannabinoids by UPLC combined with ionic mobility mass spectrometry (TWIM-MS)—Part I

International Journal of Mass Spectrometry

Volumn 418, Issue , 2017, Pages 112-121

  Tose, Lilian V ^a   Santos, Nayara A ^a   Rodrigues, Rayza R T ^a   Murgu, Michael ^b   Gomes, Alexandre F ^b   Vasconcelos, Géssica A ^c   Souza, Paulo C T ^d   Vaz, Boniek G ^c   Romão, Wanderson ^a,e  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b WatersTechnologies of Brazil   (Brazil)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e Campus Vila Velha Federal Institute of Espírito Santo   (Brazil)

Author keywords

Cannabinoids; Ionic mobility; Isomers; Uplc twim ms; 9 THC

Indexed keywords

EID: 85006096985     PISSN: 13873806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijms.2016.10.018     Document Type: Article

References (44)

1. [1] United Nations Office on Drugs and Crime −UNODC, Vienna World Drug Report. Retrieved 20 2015 from http://www.unodc.org/wdr2014/ (2014).
2. [2] Boleda, M.R., Galceran, M.T., Ventura, F., Trace determination of cannabinoids and opiates in waste water and surface waters by ultra-performance liquid chromatography–tandem mass spectrometry. J. Chromatogr. A 1175 (2007), 38–48.
3. [3] Elsohly, M.A., Slade, D., Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 78 (2005), 539–548.
4. [4] Zulfiqar, F., Ross, S.A., Slade, D., Ahmed, S.A., Radwan, M.M., Ali, Z., Khan, I.A., Elsohly, M.A., Cannabisol, a novel ∆-9-THC dimer possessing a unique methylene bridge, isolated from Cannabis sativa. Tetrahedron Lett. 53 (2012), 3560–3562.
5. [5] Yamauchi, T., Shoyama, Y., Aramaki, H., Azuma, T., Nishioka, I., Tetrahydrocannabinolic acid, a genuine substance of tetrahydrocannabinol. Chem. Pharm. Bull., 15, 1967, 1075.
6. [6] Santos, N.A., Souza, L.M., Domingos, E., França, H.S., Lacerda, V. Jr., Beatriz, A., Vaz, B.G., Rodrigues, R.R.T., Carvalho, V.V., Merlo, B.B., Kuster, R.M., Romão, W., Evaluating the selectivity of colorimetric test (Fast blue BB salt) for the cannabinoids identification in marijuana street samples by UV-Vis, TLC ESI(+)MS and ESI(+)MS/MS. Foren. Chem. 1 (2016), 13–21.
7. [7] Zuardi, A.W., Crippa, J.A.S., Hallak, J.E.C., Moreira, F.A., Guimarães, F.S., Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz. J. Med. Biol. Res., 39, 2006, 421.
8. [8] Nascimento, I.R., Costa, H.B., Souza, I.M., Soprani, L.C., Merlo, B.B., Romão, W., Chemical identification of cannabinoids in street marijuana samples using electrospray ionization FT-ICR mass spectrometry. Anal. Methods 7 (2015), 1415–1424.
9. 9-THC in cannabis products. Forensic Sci. Int., 3, 2005, 149.
10. [10] Bijlsma, L., Sancho, J.V., Hernández, F., Niessen, W., Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MSE accurate‐mass spectra. J. Mass Spectrom. 46 (2011), 865–875.
11. [11] Halldin, M.M., Carlsson, S., Kanter, S.L., Widman, M., Agurell, S., Urinary metabolites of delta 1-tetrahydrocannabinol in man. Arzneimittelforschung 32 (1981), 764–768.
12. [12] Andrews, R., Paterson, S., A validated method for the analysis of cannabinoids in post-mortem blood using liquid–liquid extraction and two-dimensional gas chromatography?mass spectrometry. Foren. Sci. Int. 222 (2012), 111–117.
13. 9‐THCA‐A) in rat using LC‐MS/MS, LC‐QTOF MS and GC‐MS techniques. J. Mass Spectrum. 44 (2009), 1423–1433.
14. [14] Bordin, D.C., Messias, M., Lanaro, R., Cazenave, S.O.S., Costa, J.L., Análise forense: pesquisa de drogas vegetais interferentes de testes colorimétricos para identificação dos canabinóides da maconha (Cannabis Sativa L.). Quím. Nova 35 (2012), 2040–2043.
15. [15] United Nations Office on Drugs and Crime − UNODC, Recommended methods for the identification and analysis of cannabis and cannabis products. New York. Retrieved Jan. 2016, from http://www.unodc.org/documents/scientific/ST-NAR-40-Ebook.pdf (2009).
16. [16] Mosquera, J.T., Marihuana − cannabis − aspectos toxicologicos, clinicos, sociales y potenciales usos terapeuticos. UNODC, 2015.
17. [17] Schwope, D.M., Scheidweiler, K.B., Huestis, M.A., Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry. Anal. Bioanal. Chem. 401 (2011), 1273–1283.
18. [18] Kuwayama, K., Yamamuro, T., Tsujikawa, K., Miyaguchi, H., Kanamori, T., Iwata, Y.T., Inoue, H., Utilization of matrix-assisted laser desorption/ionization imaging mass spectrometry to search for cannabis in herb mixtures. Anal. Bioanal. Chem. 406 (2014), 4789–4794.
19. [19] Lacroix, C., Saussereau, E., Fast liquid chromatography/tandem mass spectrometry determination of cannabinoids in micro volume blood samples after dabsylderivatization. J. Chromatogr. B 905 (2012), 85–95.
20. [20] Grauwiler, S.B., Scholer, A., Drewe, J., Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts. J. Chromatogr. B 850 (2007), 515–522.
21. [21] Astarita, G., Paglia, G., Yu, K., Ion-Mobility Mass Spectrometry in Metabolomics and Lipidomics MS − The Practical Art. LC.GC Europe. 2015, Waters Corporation, USA (September).
22. [22] Kanu, A.B., Dwivedi, P., Tam, M., Matz, I., Hill, H.H., Ionmobility-massspectrometry. J. Mass Spectrom. 43 (2008), 1–22.
23. [23] Shvartsburg, A.A., Smith, R.D., Fundamentals of traveling wave ion mobility spectrometry. Anal. Chem. 80 (2008), 9689–9699.
24. [24] Gwak, S., Almirall, J.R., Rapid screening of 35 new psychoactive substances by ion mobility spectrometry (IMS) and direct analysis in real time (DART) coupled to quadrupole time‐of‐flight mass spectrometry (QTOF‐MS). Drug Test Anal. 7 (2015), 884–893.
25. [25] Gray, C.J., Thomas, B., Upton, R., Migas, L.G., Eyers, C.E., Barran, P.E., Flitsch, S.L., Applications of ion mobility mass spectrometry for high throughput, high resolution glycan analysis. Biochim. Biophys. Acta 1860 (2016), 1688–1709.
26. [26] Ahonen, L., Fasciotti, M., Gennäs, G.B., Kotiaho, T., Daroda, R.J., Eberlin, M.N., Kostiainen, R., Separation of steroid isomers by ion mobility mass spectrometry. J. Chromatogr. A 1310 (2013), 133–137.
27. [27] Williams, M.D., Zhang, X., Belton, A.S., Xian, L., Huso, T., Park, J.J., Siems, W.F., Gang, D.R., Resar, I.M.S., Reeves, R., Hill, H. Jr., HMGA1 drives metabolic reprogramming of intestinal epithelium during hyperproliferation polyposis, and colorectal carcinogenesis. J. Proteome Res. 14 (2015), 1420–1431.
28. [28] Fasciotti, M., Sanvido, G.B., Santos, V.G., Lalli, P.M., McCullagh, M., de Sá, G.F., Daroda, R.J., Peter, M.G., Eberlin, M.N., Separation of isomeric disaccharides by traveling wave ion mobility mass spectrometry using CO2 as drift gas. J. Mass Spectrom. 47 (2012), 1643–1647.
29. [29] Romão, W., Lalli, P.M., Franco, M.F., Sanvido, G., Schwab, N.V., Lanaro, R., Costa, J.L., Sabino, B.D., Bueno, M.I.M.S., Sá, G.F., Daroda, R.J., Souza, V., Eberlin, M.N., Chemical profile of meta-chlorophenylpiperazine (m-CPP) in ecstasy tablets by easy ambient sonic-spray ionization X-ray fluorescence, ion mobility mass spectrometry and NMR. Anal. Bioanal. Chem. 400 (2011), 3053–3064.
30. [30] Armenta, S., Garrigues, S., La Guardia, M., Brassier, J., Alcalá, M., Blanco, M., Perez-Alfonso, C., Galipienso, N., Detection and characterization of emerging psychoactive substances by ion mobility spectrometry. Drug Test.Anal. 7 (2015), 280–289.
31. [31] Hanwell, M.D., Curtis, D.E., Lonie, D.C., Vandermeersch, T., Zurek, E., Hutchison, G.R., Avogadro: an advanced semantic chemical, editor, visualization, and analysis platform. J. Cheminform., 4(1), 2012, 17.
32. [32] M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G., Scalmani, V., Barone, B., Mennucci, G. A. Petersson, H., Nakatsuji, M., Caricato, X., Li, H. P. Hratchian, A. F. Izmaylov, J., Bloino, G., Zheng, J. L. Sonnenberg, M., Hada, M., Ehara, K., Toyota, R., Fukuda, J., Hasegawa, M., Ishida, T., Nakajima, Y., Honda, O., Kitao, H., Nakai, T., Vreven, J. A. Montgomery Jr., J. E. Peralta, F., Ogliaro, M., Bearpark, J. J. Heyd, E., Brothers, K. N. Kudin, V. N. Staroverov, R., Kobayashi, J., Normand, K., Raghavachari, A., Rendell, J. C. Burant, S. S. Iyengar, J., Tomasi, M., Cossi, N., Rega, J. M. Millam, M., Klene, J. E. Knox, J. B. Cross, V., Bakken, C., Adamo, J., Jaramillo, R., Gomperts, R. E. Stratmann, O., Yazyev, A. J. Austin, R., Cammi, C., Pomelli, J. W. Ochterski, R. L. Martin, K., Morokuma, V. G. Zakrzewski, G. A. Voth, P., Salvador, J. J. Dannenberg, S., Dapprich, A. D. Daniels, Ö., Farkas, J. B. Foresman, J. V. Ortiz, J., Cioslowski, D. J. Fox, Gaussian 09, Revision E. 01; Gaussian, (2009).
33. [33] Humphrey, W., Dalke, A., Schulten, K.J., VMD: visual molecular dynamics. Molec. Graph, 14, 1996, 33.
34. [34] Vanommeslaeghe, K., MacKerell, A.D., Automation of the CHARMM general force field (CGenFF) I: bond perception and atom typing. J. Chem. Inf. Model, 52, 2012, 3144.
35. [35] Mesleh, M.F., Hunter, J.M., Shvartsburg, A.A., Schatz, G.C., Jarrold, M.F., J. Phys. Chem, 100(40), 1996, 16082.
36. [36] Shvartsburg, A.A., Jarrold, M.F., Chem. Phys. Lett., 261(1–2), 1996, 86.
37. [37] Campuzano, I., Bush, M.F., Robinson, C.V., Beaumont, C., Richardson, K., Kim, H., Kim, H.I., Anal. Chem., 84(2), 2012, 1026.
38. [38] Lewis, G.S., Turner, C.E., Constituents of Cannabis sativa L. XIII: Stability of dosage form prepared by impregnating synthetic (–)-delta 9-trans-tetrahydrocannabinol on placebo Cannabis plant material. J. Pharm. Sci., 67, 1978, 876.
39. [39] Elsohly, M.A., Marijuana and the cannabinoids. Forensic Science and Medicine, 2007, Humana Press.
40. [40] Eiras, M.M., Oliveira, D.N., Ferreira, M.S., Benassi, M., Cazenave, S.O.S., Catharino, R.R., Fast fingerprinting of cannabinoid markers by laser desorption ionization using silica plate extraction. Anal. Methods 6 (2014), 1350–1352.
41. [41] Relatório anual Departamento de Polícia Federal. Relatório de atividades. Retrieved 01 Mar. 2015, from http://www.dpf.gov.br/institucional/relatorio-anual-pf/ (2008).
42. 9-tetrahydrocannabinol in men and women. Clin. Pharmacol. Ther. 34 (1983), 352–363.
43. [43] Watanabe, K., Yamaori, S., Funahashi, T., Kimura, T., Yamamoto, I., Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci. 80 (2007), 1415–1419.
44. [44] Fasciotti, M., Lalli, P.M., Heerdt, G., Steffen, R.A., Corilo, Y.E., Sá, G.F., Dadora, R.J., Reis, F.A.M., Morgon, N.H., Pereira, R.C.L., Eberlin, M.N., Klitzke, C.F., Structure-drift time relationships in ion mobility mass spectrometry. Int. J. Ion Mobility Spectrom. 16 (2013), 117–132.